首页> 美国卫生研究院文献>Current Controlled Trials in Cardiovascular Medicine >Recommendations and evidence for reporting items in pediatric clinical trial protocols and reports: two systematic reviews
【2h】

Recommendations and evidence for reporting items in pediatric clinical trial protocols and reports: two systematic reviews

机译:儿科临床试验方案和报告中报告项目的建议和证据:两项系统评价

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundComplete and transparent reporting of clinical trial protocols and reports ensures that these documents are useful to all stakeholders, that bias is minimized, and that the research is not wasted. However, current studies repeatedly conclude that pediatric trial protocols and reports are not appropriately reported. Guidelines like SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials) and CONSORT (Consolidated Standards of Reporting Trials) may improve reporting, but do not offer guidance on issues unique to pediatric trials. This paper reports two systematic reviews conducted to build the evidence base for the development of pediatric reporting guideline extensions: 1) SPIRIT-Children (SPIRIT-C) for pediatric trial protocols, and 2) CONSORT-Children (CONSORT-C) for pediatric trial reports.
机译:背景技术完整,透明的临床试验方案和报告报告可确保这些文件对所有利益相关者均有用,可将偏见降至最低,并且不会浪费研究资源。但是,当前的研究反复得出结论,没有适当地报告儿科试验方案和报告。诸如SPIRIT(标准方案项目:介入试验的建议)和CONSORT(报告试验的合并标准)之类的指南可能会改善报告质量,但不能提供有关儿科试验独有问题的指南。本文报告进行了两次系统的审查,以建立用于扩展儿科报告指南扩展的证据基础:1)SPIRIT-Children(SPIRIT-C)用于儿科试验方案,以及2)CONSORT-Children(CONSORT-C)用于儿科试验报告。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号